Organic Chemistry TRIZ Cases

Conventional hole-transport materials limit luminous efficiency and lifetime; tetraphenylethenyl amine helps stabilize charge and reduce degradation.

TRPC5-inhibiting pyridazinones target podocyte injury and proteinuria, addressing relapse risk and side effects linked to conventional treatments.

Membrane pervaporation removes water from t-butyl hydroperoxide mixtures before epoxidation, helping limit byproducts and improve propylene oxide selectivity.

DCN-1-modulating compounds induce fetal hemoglobin to address inadequate treatments for sickle cell disorders and thalassemia.

Non-selective glutamine inhibitors can suppress tumors but cause gastrointestinal toxicity and myelosuppression; this case develops selective analogues.

Targeting Myt1 kinase addresses cancers with lost G1 checkpoints by inducing death in CCNE1-overexpressing or FBXW7-mutated cells.

Mutant IDH1 and IDH2 generate cancer-promoting R(−)-2-hydroxyglutarate; inhibitor compounds target this activity for treatment.

Small molecules mimic the closed L2′ loop conformation to stabilize caspase-8/c-FLIPL dimers and enhance apoptosis in resistant cancer cells.

Sequential solvent extraction and liquid-liquid purification improve akuamma alkaloid reproducibility before chemical modification into derivatives.

CAPY-AP fluorescent staining reveals enlarged or multiple nucleoli, adding rapid cancer-versus-normal tissue evidence beyond H&E staining.

See how modified AMPK inhibitor structures improve specificity and nanomolar potency while limiting off-target kinase inhibition.

Formula I compounds target ROS1, NTRK, and ALK, including resistant variants, to broaden kinase inhibition for resistant cancers.

A donor–acceptor quinoid compound forms a pn-junction photoelectric layer that absorbs 800–3000 nm infrared light for higher sensor sensitivity.

See how phosgene-based N-carboxyanhydride preparation removes unsaturated compounds to improve yield and reduce chloride impurities.

Slo-1-targeting compounds address helminth resistance by inhibiting nematodes and filariae with activity at low dosages.

Truncated itraconazole analogues modify the scaffold and substituents to inhibit Hh signaling while retaining activity against Smo mutants.

A formula I heterocyclic compound inhibits CDK12, suppressing DNA repair and inducing cancer-cell death as a potential treatment approach.

Acetic anhydride intermediates support high-purity, large-scale synthesis of biologically active heterocyclic compounds.

Defined crystalline polymorphs and salt forms address BTK inhibitor stability, isolation, and scale-up manufacturing needs.

Specific ring structures and substituents help blue OLED emission layers lower driving voltage while improving external quantum efficiency.

Synthetic mesembrine and mesembrenone analogs address variable plant extracts and nausea-linked PDE4 inhibition with improved stability.

Tailored organic compounds improve hole transport to lower driving voltage, raise luminescence efficiency, and extend blue-device lifespan.

High renal and salivary gland uptake limits PSMA radiopharmaceuticals; N-methylated linker amino acids support clearance while preserving target binding.

High-CBD hemp products can contain unwanted psychoactive THC; purification and controlled cannabinoid conversion create tailored ratios with THC below 0.01%.

KAT6 inhibitor compounds target aberrant acetylation in breast cancer while improving selectivity and limiting off-target effects.

Two host compounds balance hole and electron mobility, increase exciton formation, and extend OLED lifespan.

Poor-prognosis MLL-fusion leukemia drives the need for compounds that inhibit menin interactions with MLL oncoproteins.

Red OLED hosts face injection barriers and molecular defects; carbazole–heteroarylene compounds stabilize amorphous films and improve exciton energy transfer.

Existing remibrutinib routes can form nitrosamines; alternative intermediates and crystallization lower impurities below 1000 ppb.

These heteroaromatic small molecules inhibit tau oligomer formation through oral dosing, addressing the cost and convenience limits of immunotherapy.

An aqueous mercaptan-and-base mixture extracts CS2 from sulfide streams, delivering below 100 ppmw after phase separation.

Selective 15-PGDH modulators control prostaglandin levels by tissue, balancing regeneration benefits with colon tumor risk.

Metal salt forms a protective film that limits methanesulfonic acid corrosion and paraformaldehyde blockage during continuous trioxane production.

A hydrohalide tertiary-amino group on an anion-exchange resin provides high catalytic activity with easy solid-liquid separation.

Selective receptor binding targets THR-β in liver disorders while limiting cardiac side effects associated with less selective agonists.

Isourea and isothiourea compounds use structural variations to address limited ferroptosis targeting in cancer treatment.

Balancing chloroacetamide reactivity with acrylamide selectivity, sulfamate acetamides enable cysteine labeling and covalent payload release.

See how lactate/ketone body esters convert into lactate and BHB, delivering metabolic substrates while minimizing harmful ion loads.

Single-target epigenetic inhibition can limit cancer treatment efficacy; this hydroxyamide compound combines LSD1 and HDAC inhibition in one molecule.

Novel sulfur-containing ionizable lipids in lipid nanoparticles improve extrahepatic nucleic acid delivery and may reduce the required dose.

Ring A, ring B, and saturation changes tune GPR65 activity and selectivity while targeting oral pharmacokinetic profiles for cancer and autoimmune disease therapy.

Defined salts and crystalline forms address small-molecule CBP/p300 inhibition challenges by improving solubility, dissolution, bioavailability, and stability.

Defined amine compounds improve hole transport in functional layers, increasing luminous efficiency in light-emitting elements.

An azine-core, carbazole-derived compound suppresses dopant interference in OLED emission layers to improve color purity, efficiency, and lifespan.

Epigenetic HDAC inhibition modulates the tumor microenvironment to improve antigen presentation and counter low immunotherapy response.

Replacing costly natural ambergris, these formula (I) compounds deliver woody amber notes with improved biodegradability and lower use concentrations.

Inhaled CK1δ/ε inhibitors address TGF-β-related ICS insensitivity while extending pulmonary residence and limiting systemic exposure.

Alkyloxy anthracene-9,10-diones generate bleaching-active species under visible light, improving removal of polymerizable dyes and textile soils.

Imide compounds form heat-resistant organic underlayer films with stable thickness, strong substrate adhesion, and reliable filling and planarization.

Controlled glycidyl ether synthesis limits hydrolyzable chlorine and hydroxyl groups for stable, heat-resistant epoxy materials.

An optical film containing benzotriazole and SiO2 absorbs blue light in the 415 to 455 nm range.

A lithography underlayer film material combines specific polymer components to achieve high heat resistance and etching resistance.

Acid catalysis suppresses 4-oxo-3,4-dihydroquinazoline formation during tetrazole-substituted anthranilic diamide synthesis.

Composite polyoxazolidines prevent crystallization during storage and transport without solvents.

Segmented electron transport layers balance hole and electron flow to extend blue OLED lifespan.

Novel coumarin compounds enable non-invasive refractive power adjustment in intraocular lenses through photodimerization.

A light emitting device uses a pyrromethene compound combined with a naphthacene derivative in the emissive layer to achieve high luminance efficiency.

Replacing expensive phthalimide protection with direct amino precursors cuts raw material costs and energy consumption during industrial manufacturing.

Alkali precipitation and optimized column chromatography extract ≥80% pure total ginkgolide, bypassing complex multi-step recrystallization.

Form K prevents amorphous conversion during drying by maintaining crystallinity and reducing hygroscopicity.

A liquid stabilizer mixture containing branched polymers and UV absorbers protects organic materials.

Ionic liquid catalyst enables high-yield imidazole synthesis without solvents, resolving productivity and manufacturing complexity trade-offs.

Metal complex catalyst enables benzoxazine mixture rapid low-temperature curing, preventing thermal stability loss and weight degradation.

A pyrene-triazine compound improves carrier transport in organic electronic components.

Segmenting the degrader into binding motifs resolves complexity while enabling selective TEAD destruction through the ubiquitin proteasome system.

Benzosulfonyl compounds inhibit the YAP/TAZ-TEAD interaction, addressing the lack of specific inhibitors for cancers like mesothelioma.

Benzonitrile derivatives incorporate water-soluble groups to reduce liver accumulation and improve tumor enrichment.

Composite polyhydroxystyrene and poly(meth)acrylate resins resolve the trade-off between dry etching resistance and alkali development properties.

Incorporating 1,3-propanediol with an alicyclic skeleton into the polyester polyol provides acid and alkali resistance without compromising flexibility.

Chemically amplified negative resist composition incorporates a silicone structure-bearing polymer to enhance substrate adhesion.

Small molecule agonists activate and internalize EphA2 receptors, resolving the contradiction between oncogenic promotion and tumor suppression.

Anhydrous solvent processing stabilizes nucleic acids during encapsulation, preventing degradation in aqueous environments.

Substituted quinazoline compounds inhibit protein kinases like B-Raf and B-Raf(V600E), addressing limited efficacy and drug resistance in cancer treatment.

Replacing potassium tert-butoxide with sodium hydroxide eliminates explosion risks and simplifies purification via crystallization.

Pyridazinone and pyridone compounds inhibit SSAO/VAP-1 enzymatic activity, reducing leukocyte adhesion and inflammatory processes.

Suzuki cross-coupling overcomes modest yields and limited partner scope in DHPP synthesis.

A water-soluble photoactivator generates active agents via visible light excitation.

Organic matter selectively deposits on metal or metal oxide surfaces while avoiding nonmetallic inorganic materials.

Xylene replaces toxic toluene for safer cannabinol conversion.

A host compound in the light emitting layer transports holes to boost exciton formation.

A tin-plated copper electrical connection utilizes a surface treating layer containing metal affinity compounds to stabilize the base oil film on dissimilar metal interfaces.

A spiro-anthracene core compound with aromatic substituents enhances blue emission in organic light-emitting diodes.

Aromatic amine derivative with dibenzofuran and terphenyl structures serves as a hole transporting layer in organic electroluminescence devices.

Specific R group modifications eliminate Grignard side reactions and accelerate styrenic polymerization rates for scalable industrial production.

A non-metal tanning process uses sulfonated triazine derivatives to produce metal-free leather with high shrinkage temperature.

Novel (aza)benzhydryl ether derivatives target the histamine H4 receptor to modulate inflammatory processes.

A sulfanyl sulfonic acid compound modifies rubber viscoelasticity through specific molecular interactions.

Introducing dithiocarbamate moieties into myricetin structures boosts cancer cell inhibition rates beyond traditional drug benchmarks.

Specific bipolar hosts and triphenylene derivatives optimize energy transfer to extend device lifetime and efficiency in green phosphorescent OLEDs.

Cryogenic grinding and controlled decarboxylation preserve volatile compounds and waxes, maintaining the entourage effect while ensuring extract stability.

Polyaddition of multifunctional amines and acrylates yields branched oligomers with controlled viscosity, resolving uncontrolled chain extension.

Formula I compounds inhibit gut microbiota choline conversion to trimethylamine, lowering cardiovascular disease risk.

Formula I bis-indole hosts enhance device efficiency and lower operation voltage by optimizing molecular structure parameters for superior charge conduction.

Replacing hydrochloric acid with zinc dichloride in alcohol-halogenated hydrocarbon solvents improves yield and eliminates complex purification steps.